Grant-in-Aid Awards

FAST Grant-in-Aid awards are smaller, one-time grants aimed to provide funds for needed equipment, reagents, or research costs to further promising projects on Angelman syndrome. Typical awards total approximately $10,000, but FAST will consider additional funding if warranted.
Looking for our deadline?

There isn’t one. All grant applications are considered on a rolling basis. We move fast so you can too.

The Grant-In-Aid program will provide targeted funding to enable research projects on Angelman syndrome to proceed at a rapid pace. These one-time awards are not meant to be the sole support for a research project, but are, instead, envisioned to enable capitalization upon findings from current projects, allow for exploratory experiments, or provide funding for reagents or equipment necessary to move research forward.

There is no predetermined amount of award. We anticipate investigators applying for what they need. However, only under special circumstances do we anticipate awards in excess of $10,000. Applicants are encouraged to contact FAST at to determine the feasibility of a potential request prior to applying.


Institutions receiving grants must be recognized as nonprofit. In the US, this means institutions that do not operate to make a profit. Individuals should have training and experience at least equal to the PhD or MD level. Awardees are required to pursue their research and academia on a full-time basis or as specified by the sponsoring institution in accordance with its own policies.

Duration of Support

Grants-in-Aid are one time awards. A financial report and progress report are required within one year of the award activation date.

Allowable Cost Policy

Potential allowable costs include:

  • Reagents and Services: These may include but are not limited to: gene chips, chemical libraries, acquisition of cell lines, acquisition of animal model lines.

  • Services: These may include, but are not limited to: genetic sequencing, proteomics, metabolomics, mass spectrometry, antibody production, and drug/chemical manufacturing.

  • Equipment: FAST will consider the purchase of specialized pieces of equipment or software purchases for specific projects when necessary.

Costs that are not allowable:

  • Personnel: Including salary and fringe benefits. Additionally, FAST will fund postdoctoral and graduate students at a salary equivalent to the current NIH guidelines.

  • Indirect Costs

  • General office supplies/equipment

  • Bridging funds to cover gaps in grant funding

Application and Submission Information

Applicants should prepare a one-page Letter of Intent and include the following:

  • Hypotheses and Specific Aims: Include specific research questions, objectives and hypotheses. The focus of the applications should be aligned with the FAST mission.

  • Lay Summary: This should include your research objectives and the potential your work has to help those with Angelman syndrome. The lay summary should be easily interpreted by a lay person. We are committed to educating the public about the importance of this research, this lay summary is an important part of the application process. This will be posted on the FAST website if the project is funded.

  • Budget:

    • Detailed budget, keeping in mind what costs are allowable and not allowable.

    • Biosketch: The biosketch of the PI and any collaborative personnel for the project should be included but does fall within the 1 page limit. Please use the current NIH Biosketch format.


  • Proposal in Arial or Times New Roman size 11 point font, single or 1.15 spacing;

  • Margins no less than 0.5”;

  • Include a header on each page indicating name of PI (Last, First), page number;

  • Figures and figure legends included within the 5 page limit; and

  • Only PDF files accepted for review.

Submit Application Materials

Applications must be submitted electronically to Only PDF files will be accepted and reviewed. Applications will be accepted on a rolling basis. Any questions about the application process should be directed to

Download a printable copy here.

Angelman Syndrome News